REDECTANE Trademark

Trademark Overview

On Thursday, September 19, 2013, a trademark application was filed for REDECTANE with the United States Patent and Trademark Office. The USPTO has given the REDECTANE trademark a serial number of 79141780. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, September 18, 2023. This trademark is owned by Wilex AG. The REDECTANE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and/or prevention of cancer and oncological diseases; medical preparations for the health care, namely, preparations for the treatment of cancer and oncological diseases; medicines for human purposes, in particular for the treatment of cancer and oncological diseases; diagnostic preparations for medical purposes

Research in the field of biotechnology and development of pharmaceutical preparations and drugs
redectane

General Information

Serial Number79141780
Word MarkREDECTANE
Filing DateThursday, September 19, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, September 18, 2023
Registration Number4643070
Registration DateTuesday, November 25, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 9, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and/or prevention of cancer and oncological diseases; medical preparations for the health care, namely, preparations for the treatment of cancer and oncological diseases; medicines for human purposes, in particular for the treatment of cancer and oncological diseases; diagnostic preparations for medical purposes
Goods and ServicesResearch in the field of biotechnology and development of pharmaceutical preparations and drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 11, 2021
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 11, 2021
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameWilex AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameWilex AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameWilex AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, January 30, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 4, 2014APPLICATION FILING RECEIPT MAILED
Saturday, February 22, 2014REFUSAL PROCESSED BY IB
Wednesday, June 25, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, January 31, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 31, 2014ASSIGNED TO EXAMINER
Monday, February 3, 2014NON-FINAL ACTION WRITTEN
Tuesday, February 4, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 4, 2014REFUSAL PROCESSED BY MPU
Tuesday, February 4, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 25, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 4, 2014ASSIGNED TO LIE
Tuesday, July 8, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 8, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 8, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 11, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, July 11, 2014EXAMINERS AMENDMENT E-MAILED
Friday, July 11, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 11, 2014EXAMINER'S AMENDMENT ENTERED
Friday, July 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 25, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 11, 2021CANCELLED SECTION 71
Monday, August 4, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 20, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 9, 2014PUBLISHED FOR OPPOSITION
Tuesday, September 9, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 25, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, February 25, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 22, 2015FINAL DISPOSITION PROCESSED
Wednesday, April 22, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 8, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, April 14, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 14, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, April 14, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, July 17, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 11, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, June 11, 2022INVALIDATION PROCESSED
Saturday, June 11, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

redectane preparations oncological cancer diseases treatment medical purposes pharmaceutical field research